Skip to main content
. 2019 Aug 6;13:360. doi: 10.3389/fncel.2019.00360

FIGURE 6.

FIGURE 6

Silencing TMEM16A exerts its BBB protective effect by decreasing ICAM-1 expression via the NF-κB signaling pathway. (A,B) ICAM-1 protein expression following OGD/R treatments with TMEM16A knockdown, with or without PDTC treatment. (C) Quantification of transendothelial permeability detected by dextran leakage and (D) a TEER assay. Values are the mean ± SEM. Two asterisks indicate P < 0.01 vs. control groups. One number sign indicates P < 0.05 and two number signs indicate P < 0.01 vs. OGD/R alone groups.